According to our knowledge, the present study is the first to compare the diagnostic characteristics of CXCL-8 with the well-established tumor markers (CEA and SCC-Ag) and the marker of inflammation—CRP in the sera of OC patients. This evidence concerns the gene CEACAM5 and neoplasm.